Cargando…
Quantification and composition of pharmaceutical waste in New Zealand
This study aimed to quantify the amount of pharmaceutical waste produced in New Zealand, and determine the composition of pharmaceutical waste from community pharmacies in Auckland, New Zealand. Pharmaceutical waste collected in New Zealand is increasing, peaking at 542 tonne in 2019. Pharmaceutical...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085561/ https://www.ncbi.nlm.nih.gov/pubmed/35570848 http://dx.doi.org/10.1007/s10163-022-01410-z |
_version_ | 1784703847391821824 |
---|---|
author | Hanning, Sara M. Hua, Changji Baroutian, Saeid Burrell, Rob Taylor, Matthew Wright, L. James Svirskis, Darren |
author_facet | Hanning, Sara M. Hua, Changji Baroutian, Saeid Burrell, Rob Taylor, Matthew Wright, L. James Svirskis, Darren |
author_sort | Hanning, Sara M. |
collection | PubMed |
description | This study aimed to quantify the amount of pharmaceutical waste produced in New Zealand, and determine the composition of pharmaceutical waste from community pharmacies in Auckland, New Zealand. Pharmaceutical waste collected in New Zealand is increasing, peaking at 542 tonne in 2019. Pharmaceutical waste collected from hospitals and pharmacies in Auckland increased by more than fourfold from 2016 to 2020. An audit of the types of pharmaceutical waste collected from community pharmacies revealed that the most common classes of drugs identified in this waste stream belonged to the nervous system, cardiovascular system and alimentary tract, and metabolism. Following examination of the contents of 12 pharmaceutical waste bins, 475 different pharmaceutical products were identified, highlighting the breadth of drugs in this waste stream. A range of dosage forms and hence materials were identified, which could present challenges for future waste treatment approaches. Hazardous drugs were identified including cytotoxic compounds, which should go into a separate waste stream for incineration. There is a need for similar data to be collected from multiple sites to fully appreciate the magnitude and composition of pharmaceutical waste. This will allow for the suitability of current practices for managing this hazardous waste stream to be evaluated. |
format | Online Article Text |
id | pubmed-9085561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-90855612022-05-10 Quantification and composition of pharmaceutical waste in New Zealand Hanning, Sara M. Hua, Changji Baroutian, Saeid Burrell, Rob Taylor, Matthew Wright, L. James Svirskis, Darren J Mater Cycles Waste Manag Regional Case Study This study aimed to quantify the amount of pharmaceutical waste produced in New Zealand, and determine the composition of pharmaceutical waste from community pharmacies in Auckland, New Zealand. Pharmaceutical waste collected in New Zealand is increasing, peaking at 542 tonne in 2019. Pharmaceutical waste collected from hospitals and pharmacies in Auckland increased by more than fourfold from 2016 to 2020. An audit of the types of pharmaceutical waste collected from community pharmacies revealed that the most common classes of drugs identified in this waste stream belonged to the nervous system, cardiovascular system and alimentary tract, and metabolism. Following examination of the contents of 12 pharmaceutical waste bins, 475 different pharmaceutical products were identified, highlighting the breadth of drugs in this waste stream. A range of dosage forms and hence materials were identified, which could present challenges for future waste treatment approaches. Hazardous drugs were identified including cytotoxic compounds, which should go into a separate waste stream for incineration. There is a need for similar data to be collected from multiple sites to fully appreciate the magnitude and composition of pharmaceutical waste. This will allow for the suitability of current practices for managing this hazardous waste stream to be evaluated. Springer Japan 2022-05-10 2022 /pmc/articles/PMC9085561/ /pubmed/35570848 http://dx.doi.org/10.1007/s10163-022-01410-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Regional Case Study Hanning, Sara M. Hua, Changji Baroutian, Saeid Burrell, Rob Taylor, Matthew Wright, L. James Svirskis, Darren Quantification and composition of pharmaceutical waste in New Zealand |
title | Quantification and composition of pharmaceutical waste in New Zealand |
title_full | Quantification and composition of pharmaceutical waste in New Zealand |
title_fullStr | Quantification and composition of pharmaceutical waste in New Zealand |
title_full_unstemmed | Quantification and composition of pharmaceutical waste in New Zealand |
title_short | Quantification and composition of pharmaceutical waste in New Zealand |
title_sort | quantification and composition of pharmaceutical waste in new zealand |
topic | Regional Case Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085561/ https://www.ncbi.nlm.nih.gov/pubmed/35570848 http://dx.doi.org/10.1007/s10163-022-01410-z |
work_keys_str_mv | AT hanningsaram quantificationandcompositionofpharmaceuticalwasteinnewzealand AT huachangji quantificationandcompositionofpharmaceuticalwasteinnewzealand AT baroutiansaeid quantificationandcompositionofpharmaceuticalwasteinnewzealand AT burrellrob quantificationandcompositionofpharmaceuticalwasteinnewzealand AT taylormatthew quantificationandcompositionofpharmaceuticalwasteinnewzealand AT wrightljames quantificationandcompositionofpharmaceuticalwasteinnewzealand AT svirskisdarren quantificationandcompositionofpharmaceuticalwasteinnewzealand |